ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 700,000 | $191,611,000 | 13.71% | ||
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 310,987 | $85,126,471 | +2374% | 0.09% |
| 3. | Squarepoint Ops LLC Maxime Fortin (Cio) | 249,595 | $68,321,639 | -55% | 0.07% |
| 4. | Giverny Capital Francois Rochon | 235,418 | $64,440,969 | 2.06% | |
| 5. | AQR Capital Management Cliff Asness | 222,111 | $60,767,551 | +20% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | $171,926.31 | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $252.05 | 2,000 | $504,100.00 | 66,110 | 2025-11-12 | Filing | |
| $250.25 | 487 | $121,871.75 | 5,319 | 2025-11-11 | Filing | |
| $249.75 | 8,011 | $2,000,772.89 | 467,866 | 2025-11-07 | Filing | |
| $247.54 | 3,000 | $742,620.00 | 85,745 | 2025-11-03 | Filing | |
| $282.85 | 8,009 | $2,265,332.03 | 467,792 | 2025-10-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,040,440 | $5,211,939,642 | 0.08% | |
| 2. | 12,277,966 | $3,360,847,519 | 0.06% | |
| 3. | 6,549,164 | $1,792,702,662 | 0.06% | |
| 4. | 4,552,916 | $1,246,269,745 | 0.22% | |
| 5. | 4,251,688 | $1,159,544,500 | 0.07% |
News See All
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress
ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care solutions.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone. Dr.
ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Q4 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
Jim Cramer Says The Day "Everything's A Lot More Expensive" Is Coming & Discusses These 10 Stocks
"I've worked for Time for a while . . very few people actually do David anything that's contemporaneous, so to speak, so you're looking at something . .
ResMed Inc. (NYSE:RMD) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Q3 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I will be your operator for today's call.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. (RMD) on Substack by LongTermValue Research. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.
Jim Cramer is Discussing These 10 Stocks Ahead of Q1 Earnings Season
Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a "strange" pattern.
Jim Cramer Recently Talked About These 12 Companies
Jim Cramer, host of Mad Money, warned investors on Friday that until there is more clarity regarding the tariff situation, they should brace for continued volatility.
Hedge Fund Resource Center Billionaire Hedge Funds
